Avion Wealth’s Haemonetics HAE Stock Holding History

Avion Wealth’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6	Closed	–	–	1184
2023 Q3	$0	Buy	+6	New	+$536	﹤0.01%	968

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avion Wealth's HAE Position: Q4 2023 in Review

Avion Wealth sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 6 shares.

Avion Wealth first reported a position in HAE in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

Avion Wealth reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
Avion Wealth sold 6 Haemonetics shares in Q4 2023.
Avion Wealth first reported a position in Haemonetics in Q3 2023 and held it in 1 quarter.
Avion Wealth's Haemonetics position peaked at $0 in Q3 2023.
295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on Avion Wealth's 13F filing for Q4 2023, filed 26 Jan 2024.